» Articles » PMID: 23076770

Extent of Peritumoral Brain Edema Correlates with Prognosis, Tumoral Growth Pattern, HIF1a Expression and Angiogenic Activity in Patients with Single Brain Metastases

Abstract

To analyze the prognostic value of the extent of peritumoral brain edema in patients operated for single brain metastases (BM), we retrospectively evaluated pre-operative magnetic resonance images in a discovery cohort of 129 patients and a validation cohort of 118 patients, who underwent neurosurgical resection of a single BM in two different hospitals. We recorded clinical parameters and immunohistochemically assessed the Ki67 index, the microvascularization patterns and the expression of hypoxia-induced factor 1 alpha (HIF1a) in the BM tissue specimens retrieved at neurosurgery. Statistical analysis including uni- and multivariate survival analyses were performed. Baseline characteristics were well balanced between the discovery and validation cohorts. In univariate analysis, we found a significant association of favorable overall survival time with young patient age, high Karnofsky performance score, low graded prognostic assessment (GPA) class, absence of extracranial metastases, adjuvant treatment with whole brain radiotherapy and, surprisingly, large brain edema. In multivariate analysis, only GPA and extent of brain edema remained independent prognostic parameters. The prognostic impact of the extent of brain edema was consistent in the two patient cohorts. Furthermore, we found a significant correlation of small brain edema with brain-invasive tumor growth pattern as assessed intraoperatively by the neurosurgeon, low neo-angiogenic activity and low expression of HIF1a. Extent of brain edema independently correlates with prognosis in patients operated for single BM. In conclusion, patients with small peritumoral edema have shorter survival times and their tumors are characterized by a more brain-invasive growth, lower HIF1a expression and less angiogenic activity.

Citing Articles

Predictive value of perilesional edema volume in melanoma brain metastasis response to stereotactic radiosurgery.

Yavorska M, Tomaciello M, Sciurti A, Cinelli E, Rubino G, Perrella A J Neurooncol. 2024; 170(3):611-618.

PMID: 39259411 PMC: 11615094. DOI: 10.1007/s11060-024-04818-9.


Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review.

Avino A, Ion D, Gheoca-Mutu D, Abu-Baker A, Tigaran A, Peligrad T Diagnostics (Basel). 2024; 14(7).

PMID: 38611601 PMC: 11011469. DOI: 10.3390/diagnostics14070688.


Evaluation of brain metastasis edema in breast cancer patients as a marker for Ki-67 and cell count-A single center analysis.

Stojkova M, Behme D, Barajas Ordonez F, Christ S, March C, Surov A Neuroradiol J. 2023; 37(2):178-183.

PMID: 38131219 PMC: 10973821. DOI: 10.1177/19714009231224443.


Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer.

Arrieta O, Bolano-Guerra L, Caballe-Perez E, Lara-Mejia L, Turcott J, Gutierrez S Front Oncol. 2023; 13:1251620.

PMID: 37916162 PMC: 10616784. DOI: 10.3389/fonc.2023.1251620.


Brain Metastasis Mimicking Glioma on Imaging Appearance During Tyrosine Kinase Inhibitor Administration: A Case Series and Literature Review.

Rai Y, Takami H, Kawaguchi K, Takayanagi S, Tanaka S, Yasunaga Y Cureus. 2023; 15(8):e43591.

PMID: 37719531 PMC: 10503881. DOI: 10.7759/cureus.43591.


References
1.
Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert W, Goldbrunner R, Herms J . Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2009; 16(1):116-22. DOI: 10.1038/nm.2072. View

2.
Soffietti R, Ruda R, Trevisan E . Brain metastases: current management and new developments. Curr Opin Oncol. 2008; 20(6):676-84. DOI: 10.1097/CCO.0b013e32831186fe. View

3.
Smedby K, Brandt L, Backlund M, Blomqvist P . Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer. 2009; 101(11):1919-24. PMC: 2788258. DOI: 10.1038/sj.bjc.6605373. View

4.
Steeg P, Camphausen K, Smith Q . Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011; 11(5):352-63. PMC: 7351203. DOI: 10.1038/nrc3053. View

5.
Leenders W, Kusters B, Verrijp K, Maass C, Wesseling P, Heerschap A . Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option. Clin Cancer Res. 2004; 10(18 Pt 1):6222-30. DOI: 10.1158/1078-0432.CCR-04-0823. View